Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isla S Mackenzie

Showing results (61-70 of 90) with videos related to

Pageof 9
Sort By:
BMJ Medicine|June 24, 2025
Comparative effectiveness and prescribing trends of modified release versus immediate release indapamide in patients with hypertension: cohort studyVincent Ka Chun Yan, Chengsheng Ju, Thomas MacLennan MacDonald, et al.
Trials|October 6, 2022
A cross-sectional survey on the early impact of COVID-19 on the uptake of decentralised trial methods in the conduct of clinical trialsArnela Suman, Jasmijn van Es, Helga Gardarsdottir, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 30, 2005
Aldehyde dehydrogenase 2 plays a role in the bioactivation of nitroglycerin in humansIsla S Mackenzie, Kaisa M Maki-Petaja, Carmel M McEniery, et al.
The Journal of Clinical Endocrinology and Metabolism|November 25, 2011
Evaluation of the sensitivity and specificity of (11)C-metomidate positron emission tomography (PET)-CT for lateralizing aldosterone secretion by Conn's adenomasTimothy J Burton, Isla S Mackenzie, Kottekkattu Balan, et al.
BMJ Open|February 11, 2016
Methods of a large prospective, randomised, open-label, blinded end-point study comparing morning versus evening dosing in hypertensive patients: the Treatment In Morning versus Evening (TIME) studyDavid A Rorie, Amy Rogers, Isla S Mackenzie, et al.
BMC Medicine|February 3, 2021
Impact of multiple cardiovascular medications on mortality after an incidence of ischemic stroke or transient ischemic attackTian-Tian Ma, Ian C K Wong, Cate Whittlesea, et al.
British Journal of Clinical Pharmacology|October 22, 2009
The effects of urotensin II and urantide on forearm blood flow and systemic haemodynamics in humansJoseph Cheriyan, Timothy J Burton, Timothy J Bradley, et al.
BMC Medicine|May 20, 2026
Design considerations for hypertension chronotherapy trials: insights from experience and modellingOlivia Walch, Amy Rogers, Yitong P Huang, et al.
BMC Medicine|September 12, 2021
Correction to: Impact of multiple cardiovascular medications on mortality after an incidence of ischemic stroke or transient ischemic attackTian-Tian Ma, Ian C K Wong, Cate Whittlesea, et al.
BMJ Open|August 9, 2015
Monotherapy versus dual therapy for the initial treatment of hypertension (PATHWAY-1): a randomised double-blind controlled trialThomas M MacDonald, Bryan Williams, Mark Caulfield, et al.
Pageof 9

Showing results (61-70 of 90) with videos related to

Sort By:
Pageof 9
BMJ Medicine|June 24, 2025
Comparative effectiveness and prescribing trends of modified release versus immediate release indapamide in patients with hypertension: cohort studyVincent Ka Chun Yan, Chengsheng Ju, Thomas MacLennan MacDonald, et al.
Trials|October 6, 2022
A cross-sectional survey on the early impact of COVID-19 on the uptake of decentralised trial methods in the conduct of clinical trialsArnela Suman, Jasmijn van Es, Helga Gardarsdottir, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 30, 2005
Aldehyde dehydrogenase 2 plays a role in the bioactivation of nitroglycerin in humansIsla S Mackenzie, Kaisa M Maki-Petaja, Carmel M McEniery, et al.
The Journal of Clinical Endocrinology and Metabolism|November 25, 2011
Evaluation of the sensitivity and specificity of (11)C-metomidate positron emission tomography (PET)-CT for lateralizing aldosterone secretion by Conn's adenomasTimothy J Burton, Isla S Mackenzie, Kottekkattu Balan, et al.
BMJ Open|February 11, 2016
Methods of a large prospective, randomised, open-label, blinded end-point study comparing morning versus evening dosing in hypertensive patients: the Treatment In Morning versus Evening (TIME) studyDavid A Rorie, Amy Rogers, Isla S Mackenzie, et al.
BMC Medicine|February 3, 2021
Impact of multiple cardiovascular medications on mortality after an incidence of ischemic stroke or transient ischemic attackTian-Tian Ma, Ian C K Wong, Cate Whittlesea, et al.
British Journal of Clinical Pharmacology|October 22, 2009
The effects of urotensin II and urantide on forearm blood flow and systemic haemodynamics in humansJoseph Cheriyan, Timothy J Burton, Timothy J Bradley, et al.
BMC Medicine|May 20, 2026
Design considerations for hypertension chronotherapy trials: insights from experience and modellingOlivia Walch, Amy Rogers, Yitong P Huang, et al.
BMC Medicine|September 12, 2021
Correction to: Impact of multiple cardiovascular medications on mortality after an incidence of ischemic stroke or transient ischemic attackTian-Tian Ma, Ian C K Wong, Cate Whittlesea, et al.
BMJ Open|August 9, 2015
Monotherapy versus dual therapy for the initial treatment of hypertension (PATHWAY-1): a randomised double-blind controlled trialThomas M MacDonald, Bryan Williams, Mark Caulfield, et al.
Pageof 9